Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Mar;64(3):870–877. doi: 10.1128/iai.64.3.870-877.1996

Streptococcal cysteine protease augments lung injury induced by products of group A streptococci.

T P Shanley 1, D Schrier 1, V Kapur 1, M Kehoe 1, J M Musser 1, P A Ward 1
PMCID: PMC173850  PMID: 8641794

Abstract

Streptococcus pyogenes infections in humans may be associated with severe clinical manifestations, including adult respiratory distress syndrome and a toxic shock-like syndrome. These observations have led to the investigation of products of group A streptococci that may contribute to increased virulence. Streptococcal pyrogenic exotoxin B is a highly conserved precursor of an extracellular cysteine protease that is secreted by S. pyogenes. We investigated the ability of this streptococcal cysteine protease (SCP) to act synergistically with either streptococcal cell wall antigen (SCW) or streptolysin-O (SLO) to augment lung injury in rats. Intratracheal administration of either SCW or SLO alone caused lung injury, as measured by pulmonary vascular leak. Bronchoalveolar lavage (BAL) fluid analysis showed that SCW induced neutrophil accumulation and appearance of interleukin-1beta and tumor necrosis factor alpha. In contrast, SLO induced neither neutrophil influx nor significant cytokine elevations in BAL fluids. Intratracheal administration of SCP with either SCW or SLO resulted in synergistic augmentation of lung vascular permeability and accumulation of BAL neutrophils. The synergy was reduced when SCP was either heat inactivated or coinstilled with a peptide inhibitor of the protease. SCP in the presence of SCW resulted in a significant increase in BAL fluid tumor necrosis factor alpha content but not in immunoreactive interleukin-1beta. Moreover, the copresence of SAP with SAW resulted in increased BAL fluid nitrite-nitrate levels, indicative of nitric oxide production. These data demonstrate that SCP acts synergistically with other S. pyogenes products (SCW or SLO) to increase tissue injury and provide additional evidence that SCP may function as an important virulence factor in group A streptococcal infections.

Full Text

The Full Text of this article is available as a PDF (701.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beutler B. Cachectin in tissue injury, shock, and related states. Crit Care Clin. 1989 Apr;5(2):353–367. [PubMed] [Google Scholar]
  2. Bhakdi S., Roth M., Sziegoleit A., Tranum-Jensen J. Isolation and identification of two hemolytic forms of streptolysin-O. Infect Immun. 1984 Nov;46(2):394–400. doi: 10.1128/iai.46.2.394-400.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Björck L., Akesson P., Bohus M., Trojnar J., Abrahamson M., Olafsson I., Grubb A. Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature. 1989 Jan 26;337(6205):385–386. doi: 10.1038/337385a0. [DOI] [PubMed] [Google Scholar]
  4. Cone L. A., Woodard D. R., Schlievert P. M., Tomory G. S. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med. 1987 Jul 16;317(3):146–149. doi: 10.1056/NEJM198707163170305. [DOI] [PubMed] [Google Scholar]
  5. DeVuono J., Panos C. Effect of L-form Streptococcus pyogenes and of lipoteichoic acid on human cells in tissue culture. Infect Immun. 1978 Oct;22(1):255–265. doi: 10.1128/iai.22.1.255-265.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Espevik T., Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods. 1986 Dec 4;95(1):99–105. doi: 10.1016/0022-1759(86)90322-4. [DOI] [PubMed] [Google Scholar]
  7. Ginsburg I., Gibbs D. F., Schuger L., Johnson K. J., Ryan U. S., Ward P. A., Varani J. Vascular endothelial cell killing by combinations of membrane-active agents and hydrogen peroxide. Free Radic Biol Med. 1989;7(4):369–376. doi: 10.1016/0891-5849(89)90123-8. [DOI] [PubMed] [Google Scholar]
  8. Ginsburg I., Kohen R. Synergistic effects among oxidants, membrane-damaging agents, fatty acids, proteinases, and xenobiotics: killing of epithelial cells and release of arachidonic acid. Inflammation. 1995 Feb;19(1):101–118. doi: 10.1007/BF01534384. [DOI] [PubMed] [Google Scholar]
  9. Ginsburg I., Misgav R., Pinson A., Varani J., Ward P. A., Kohen R. Synergism among oxidants, proteinases, phospholipases, microbial hemolysins, cationic proteins, and cytokines. Inflammation. 1992 Oct;16(5):519–538. doi: 10.1007/BF00918977. [DOI] [PubMed] [Google Scholar]
  10. Hackett S. P., Stevens D. L. Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis. 1992 May;165(5):879–885. doi: 10.1093/infdis/165.5.879. [DOI] [PubMed] [Google Scholar]
  11. Hoge C. W., Schwartz B., Talkington D. F., Breiman R. F., MacNeill E. M., Englender S. J. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA. 1993 Jan 20;269(3):384–389. [PubMed] [Google Scholar]
  12. Holm S. E., Norrby A., Bergholm A. M., Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis. 1992 Jul;166(1):31–37. doi: 10.1093/infdis/166.1.31. [DOI] [PubMed] [Google Scholar]
  13. Hyers T. M., Tricomi S. M., Dettenmeier P. A., Fowler A. A. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1991 Aug;144(2):268–271. doi: 10.1164/ajrccm/144.2.268. [DOI] [PubMed] [Google Scholar]
  14. Kapur V., Maffei J. T., Greer R. S., Li L. L., Adams G. J., Musser J. M. Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci. Microb Pathog. 1994 Jun;16(6):443–450. doi: 10.1006/mpat.1994.1044. [DOI] [PubMed] [Google Scholar]
  15. Kapur V., Majesky M. W., Li L. L., Black R. A., Musser J. M. Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7676–7680. doi: 10.1073/pnas.90.16.7676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kapur V., Topouzis S., Majesky M. W., Li L. L., Hamrick M. R., Hamill R. J., Patti J. M., Musser J. M. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog. 1993 Nov;15(5):327–346. doi: 10.1006/mpat.1993.1083. [DOI] [PubMed] [Google Scholar]
  17. Leon O., Panos C. Cytotoxicity and inhibition of normal collagen synthesis in mouse fibroblasts by lipoteichoic acid from Streptococcus pyogenes type 12. Infect Immun. 1983 May;40(2):785–794. doi: 10.1128/iai.40.2.785-794.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mattsson E., Rollof J., Verhoef J., Van Dijk H., Fleer A. Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infect Immun. 1994 Sep;62(9):3837–3843. doi: 10.1128/iai.62.9.3837-3843.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mulligan M. S., Hevel J. M., Marletta M. A., Ward P. A. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6338–6342. doi: 10.1073/pnas.88.14.6338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Musser J. M. Clinical relevance of streptococcal pyrogenic exotoxins in streptococcal toxic shock-like syndrome and other severe invasive infections. Pediatr Ann. 1992 Dec;21(12):821-2, 825-8. doi: 10.3928/0090-4481-19921201-08. [DOI] [PubMed] [Google Scholar]
  21. Musser J. M., Hauser A. R., Kim M. H., Schlievert P. M., Nelson K., Selander R. K. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2668–2672. doi: 10.1073/pnas.88.7.2668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schirmer W. J., Schirmer J. M., Fry D. E. Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Arch Surg. 1989 Apr;124(4):445–448. doi: 10.1001/archsurg.1989.01410040055012. [DOI] [PubMed] [Google Scholar]
  23. Suter P. M., Suter S., Girardin E., Roux-Lombard P., Grau G. E., Dayer J. M. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis. 1992 May;145(5):1016–1022. doi: 10.1164/ajrccm/145.5.1016. [DOI] [PubMed] [Google Scholar]
  24. Tracey K. J., Beutler B., Lowry S. F., Merryweather J., Wolpe S., Milsark I. W., Hariri R. J., Fahey T. J., 3rd, Zentella A., Albert J. D. Shock and tissue injury induced by recombinant human cachectin. Science. 1986 Oct 24;234(4775):470–474. doi: 10.1126/science.3764421. [DOI] [PubMed] [Google Scholar]
  25. Tracey K. J., Lowry S. F., Cerami A. Cachetin/TNF-alpha in septic shock and septic adult respiratory distress syndrome. Am Rev Respir Dis. 1988 Dec;138(6):1377–1379. doi: 10.1164/ajrccm/138.6.1377. [DOI] [PubMed] [Google Scholar]
  26. Tran Van Nhieu J., Misset B., Lebargy F., Carlet J., Bernaudin J. F. Expression of tumor necrosis factor-alpha gene in alveolar macrophages from patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1585–1589. doi: 10.1164/ajrccm/147.6_Pt_1.1585. [DOI] [PubMed] [Google Scholar]
  27. Ulich T. R., Guo K., Yin S., del Castillo J., Yi E. S., Thompson R. C., Eisenberg S. P. Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation. Am J Pathol. 1992 Jul;141(1):61–68. [PMC free article] [PubMed] [Google Scholar]
  28. Ulich T. R., Watson L. R., Yin S. M., Guo K. Z., Wang P., Thang H., del Castillo J. The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate. Am J Pathol. 1991 Jun;138(6):1485–1496. [PMC free article] [PubMed] [Google Scholar]
  29. Walmrath D., Ghofrani H. A., Rosseau S., Schütte H., Cramer A., Kaddus W., Grimminger F., Bhakdi S., Seeger W. Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxin. J Exp Med. 1994 Oct 1;180(4):1437–1443. doi: 10.1084/jem.180.4.1437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ward P. A., Mulligan M. S. Molecular mechanisms in acute lung injury. Adv Pharmacol. 1993;24:275–292. doi: 10.1016/s1054-3589(08)60940-0. [DOI] [PubMed] [Google Scholar]
  31. Warner R. L., Paine R., 3rd, Christensen P. J., Marletta M. A., Richards M. K., Wilcoxen S. E., Ward P. A. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol. 1995 Jun;12(6):649–661. doi: 10.1165/ajrcmb.12.6.7539274. [DOI] [PubMed] [Google Scholar]
  32. Werner-Felmayer G., Werner E. R., Fuchs D., Hausen A., Reibnegger G., Wachter H. Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. J Exp Med. 1990 Dec 1;172(6):1599–1607. doi: 10.1084/jem.172.6.1599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yu C. E., Ferretti J. J. Frequency of the erythrogenic toxin B and C genes (speB and speC) among clinical isolates of group A streptococci. Infect Immun. 1991 Jan;59(1):211–215. doi: 10.1128/iai.59.1.211-215.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Yu C. E., Ferretti J. J. Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains. Infect Immun. 1989 Dec;57(12):3715–3719. doi: 10.1128/iai.57.12.3715-3719.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES